probenecid has been researched along with 3-iodo-alpha-methyltyrosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores, LG; Ishikawa, N; Kawai, K; Kubodera, A; Kubota, N; Nishii, R; Shikano, N | 1 |
| Ishikawa, N; Iwamura, Y; Kawai, K; Kotani, T; Kubota, N; Nakajima, S; Nishii, R; Ogura, M; Shikano, N; Yamaguchi, N; Yoshimoto, M | 1 |
2 other study(ies) available for probenecid and 3-iodo-alpha-methyltyrosine
| Article | Year |
|---|---|
An artificial amino acid, 4-iodo-L-meta-tyrosine: biodistribution and excretion via kidney.
Topics: Amino Acids; Animals; Autoradiography; Carbon Radioisotopes; Cell Line; Epithelial Cells; Feasibility Studies; Female; Injections, Intravenous; Iodine Radioisotopes; Kidney; Methyltyrosines; Mice; Mice, Inbred Strains; Organ Specificity; Probenecid; Sensitivity and Specificity; Swine; Tissue Distribution; Tyrosine | 2003 |
Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Kidney; Male; Metabolic Clearance Rate; Methyltyrosines; Mice; Organ Specificity; Probenecid; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Uricosuric Agents | 2007 |